These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 26918654)

  • 41. Diagnostic utility of peripheral endobronchial ultrasound with electromagnetic navigation bronchoscopy in peripheral lung nodules.
    Chee A; Stather DR; Maceachern P; Martel S; Delage A; Simon M; Dumoulin E; Tremblay A
    Respirology; 2013 Jul; 18(5):784-9. PubMed ID: 23521707
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of transbronchial lung biopsy in the diagnosis of solitary pulmonary nodule.
    Trkanjec JT; Peros-Golubicić T; Grozdek D; Ivicević A; Alilović M
    Coll Antropol; 2003 Dec; 27(2):669-75. PubMed ID: 14746157
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lung cryobiopsies: a paradigm shift in diagnostic bronchoscopy?
    Poletti V; Casoni GL; Gurioli C; Ryu JH; Tomassetti S
    Respirology; 2014 Jul; 19(5):645-54. PubMed ID: 24862226
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The clinical value of autofluorescence bronchoscopy for the diagnosis of lung cancer.
    Lam B; Wong MP; Fung SL; Lam DC; Wong PC; Mok TY; Lam FM; Ip MS; Ooi CG; Lam WK
    Eur Respir J; 2006 Nov; 28(5):915-9. PubMed ID: 16870657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Automated quantitative image cytometry of bronchial washings in suspected lung cancer: comparison with cytology, histology and clinical diagnosis].
    Marek W; Krampe S; Dickgreber NJ; Nielsen L; Muti A; Khanavkar B; Müller KM; Atay Z; Topalidis T; Nakhosteen JA
    Pneumologie; 1999 Dec; 53(12):583-95. PubMed ID: 10684237
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Accuracy and feasibility of electromagnetic navigated bronchoscopy under nitrous oxide sedation for pulmonary peripheral opacities: an outpatient study.
    Bertoletti L; Robert A; Cottier M; Chambonniere ML; Vergnon JM
    Respiration; 2009; 78(3):293-300. PubMed ID: 19546519
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Advances in the diagnosis of lung cancer: contribution of molecular biology to bronchoscopic diagnosis.
    Maldonado F; Jett JR
    Curr Opin Pulm Med; 2010 Jul; 16(4):315-20. PubMed ID: 20173641
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunhistochemistry by means of widely agreed-upon markers (cytokeratins 5/6 and 7, p63, thyroid transcription factor-1, and vimentin) on small biopsies of non-small cell lung cancer effectively parallels the corresponding profiling and eventual diagnoses on surgical specimens.
    Pelosi G; Rossi G; Bianchi F; Maisonneuve P; Galetta D; Sonzogni A; Veronesi G; Spaggiari L; Papotti M; Barbareschi M; Graziano P; Decensi A; Cavazza A; Viale G
    J Thorac Oncol; 2011 Jun; 6(6):1039-49. PubMed ID: 21512408
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative analysis of cell morphology in sputum samples homogenized with dithiothreitol, N-acetyl-L cysteine, Cytorich(®) red preservative and in cellblock preparations to enhance the sensitivity of sputum cytology for the diagnosis of lung cancer.
    Saraswathy Veena V; Sara George P; Jayasree K; Sujathan K
    Diagn Cytopathol; 2015 Jul; 43(7):551-8. PubMed ID: 25881088
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Value of cytologic analysis of bronchial washings in lung cancer on the basis of bronchoscopic appearance.
    Lee GD; Kim HC; Kim YE; Lee SJ; Cho YJ; Jeong YY; Jeon KN; Jang IS; Lee JD; Hwang YS
    Clin Respir J; 2013 Apr; 7(2):128-34. PubMed ID: 22568634
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyto-histologic agreement in pathologic subtyping of non small cell lung carcinoma: review of 602 fine needle aspirates with follow-up surgical specimens over a nine year period and analysis of factors underlying failure to subtype.
    da Cunha Santos G; Lai SW; Saieg MA; Geddie WR; Pintilie M; Tsao MS; Boerner SL; Hwang D
    Lung Cancer; 2012 Sep; 77(3):501-6. PubMed ID: 22656670
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Utility of Various Bronchoscopic Modalities in Lung Cancer Diagnosis.
    Acharya K V; B U; Shenoy A; Holla R
    Asian Pac J Cancer Prev; 2017 Jul; 18(7):1931-1936. PubMed ID: 28749623
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interbronchoscopist variability in the diagnosis of lung cancer by flexible bronchoscopy.
    Minami H; Ando Y; Nomura F; Sakai S; Shimokata K
    Chest; 1994 Jun; 105(6):1658-62. PubMed ID: 8205857
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reclassification of risk of malignancy with Percepta Genomic Sequencing Classifier following nondiagnostic bronchoscopy.
    Raval AA; Benn BS; Benzaquen S; Maouelainin N; Johnson M; Huang J; Lofaro LR; Ansari A; Geurink C; Kennedy GC; Bulman WA; Kurman JS
    Respir Med; 2022; 204():106990. PubMed ID: 36283245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Usefulness of a Simple Classification for Bronchoscopic Findings for Diagnosis of Peripheral Pulmonary Tumour.
    Fukada T; Morita K; Kurimoto N; Setoguchi M; Nosaka S; Katsumata T
    Respiration; 2021; 100(8):794-803. PubMed ID: 33839728
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bronchoscopic Diagnosis of Peripheral Lung Lesions.
    Lam S; Shah PL
    Respiration; 2021; 100(8):764-766. PubMed ID: 34004606
    [No Abstract]   [Full Text] [Related]  

  • 57. Heat Induced Processing of Cellblocks with Significant Reduction in Overall Turn Around Time.
    Dhende S; Pathuthara S; Prabhudesai N; Shinde D; Karnik N; Deodhar K
    J Cytol; 2023; 40(3):126-132. PubMed ID: 37745803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bronchial washings in the diagnosis of lung cancer.
    ROSS CA; ARROYO GARCIA J; BURKE EM
    Dis Chest; 1961 Nov; 40():527-9. PubMed ID: 14494146
    [No Abstract]   [Full Text] [Related]  

  • 59. Integrating endobronchial ultrasound bronchoscopy with molecular testing of immunotherapy biomarkers in non-small cell lung cancer.
    Bozinovski S; Vannitamby A; Rangamuwa K; Aujla S; Wang H; Aloe C; Irving L; Leong TT; Steinfort DP
    Transl Lung Cancer Res; 2021 Jun; 10(6):2779-2787. PubMed ID: 34295677
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sensitive molecular testing methods can demonstrate NSCLC driver mutations in malignant pleural effusion despite non-malignant cytology.
    Steinfort DP; Kranz S; Dowers A; Leas L; Dimitriadis V; Pham K; Hsu A; Bozinovski S; Irving LB; Loveland P; Christie M
    Transl Lung Cancer Res; 2019 Aug; 8(4):513-518. PubMed ID: 31555523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.